Drug ID: | NPD7281 |
Drug Name: | Atrasentan |
Molecular Formula: | C29H38N2O6 |
Canonical SMILES: | CCCCN(C(=O)CN1C[C@@H]([C@H]([C@@H]1c1ccc(cc1)OC)C(=O)O)c1ccc2c(c1)OCO2)CCCC |
Standard InCHI: | InChI=1S/C29H38N2O6/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34)/t23-,27-,28+/m1/s1 |
Standard InCHIKey: | MOTJMGVDPWRKOC-QPVYNBJUSA-N |
Max Developmental Stage: | Phase 3 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNC000134; DCL000296 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 159594 |
ChEBI | |
CAS Number |
Molecular Weight | 510.27 |
ALogP | -2.9335 |
MLogP | 3.77 |
XLogP | 4.691 |
HDA | 5 |
HBD | 1 |
Rotatable Bonds | 17 |
TPSA | 88.54 |
RO5 Violation | 1 |